Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Eye Soft is a private U.S. information technology and artificial intelligence company based in Greer, South Carolina. The company primarily provides IT/ITES, cloud integration, business intelligence, predictive analytics, cybersecurity, and custom software services, and it is also developing the SAFER platform for predicting satellite anomalies from space weather data. In healthcare, Blue Eye Soft has promoted BlueDocAI, an AI-driven clinical decision support and medical imaging analysis tool for chest X-rays intended to help identify illnesses including COVID-19 and lung cancer. Although it has some healthcare-related activity through BlueDocAI, the company is not primarily a biotech or pharmaceutical developer and does not appear to have a traditional therapeutic pipeline. Blue Eye Soft appears to remain active as a private operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Eye Soft.